Ooi Kazuhiro

Prof. Dr. Ooi Kazuhiro

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
OKOoi Kazuhiro
Ooi Kazuhiro
MAMorio Aihara
Morio Aihara
HMHidehisa Matsumura
Hidehisa Matsumura
SMShinpei Matsuda
Shinpei Matsuda
YWYuki Watanabe
Yuki Watanabe
YMYoshizo Matsuka
Yoshizo Matsuka
Objectives Therapy outcome measures (TOMs) in temporomandibular disorders (TMDs) have not been systematically evaluated. We systematically explored the main TOM assessment methods for TMD TOMs used in previous studies. Design Scoping review. Data sources According to Preferred Reporting Items for Systematic reviews and Meta-Analysis extension for Scoping Review reporting guidelines, we systematically searched five key databases (MEDLINE/PubMed, Web of Science, Embase, Epistemonikos and ClinicalTrials) and thoroughly scanned relevant grey literature using Medical Subject Headings, Emtree and index terms. Eligibility criteria We considered primary research papers published from January 2010 to December 2020 that included patients with TMD aged ≥18 years, diagnosed according to the Diagnostic Criteria for Temporomandibular Disorders. Data extraction and synthesis Four reviewers extracted general information and information on study design and setting, target, interventions, and outcome type. Results One hundred and seventy-two of the 3726 screened articles (3704 by search engines and 22 manually) were included. The TOMs analysed included pain (n=161 articles), maximal mouth opening (MMO) (91), jaw function (32), jaw movement (26), joint sound (16), quality of life (QOL) (15), depression/anxiety (14), oral QOL (10) or others (30). Evaluation periods were <4 weeks (111), <8 weeks (62), 12 weeks (75) or ‘not mentioned’ (12). Pain outcomes (229) included general pain (115), tenderness (45), pain during functioning (44), resting pain (16) and others (8). Pain outcome evaluation methods included Visual Analogue Scale (VAS; 121), Numerical Rating Scale (21) and other methods (21). Pain outcome indicators were binary (10) or continuous (158); only five studies reported the least significant difference in treatment efficacy. MMO evaluation using painless methods (19) and jaw function evaluation using methods assessing mandibular movement range (23) were the most frequent. Conclusions TMD TOMs are diverse; the major outcomes were pain, MMO, jaw function and jaw movement. Most pain outcomes are evaluated by VAS Score changes.

17 December 2019 in Journal of Maxillofacial and Oral Surgery
Verified
Journal Article
Closed access
PDF file
OKOoi Kazuhiro
Ooi Kazuhiro
NIN. Inoue
N. Inoue
KMK. Matsushita
K. Matsushita
HYH. Yamaguchi
H. Yamaguchi
TMT. Mikoya
T. Mikoya
KTK. Tei
K. Tei

17 July 2022 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
RJRei Jokaji
Rei Jokaji
OKOoi Kazuhiro
Ooi Kazuhiro
TYTetsutaro Yahata
Tetsutaro Yahata
YNYusuke Nakade
Yusuke Nakade
SKShuichi Kawashiri
Shuichi Kawashiri
Background: The purpose of the current study was to investigate factors related to morphological changes in the masseter muscle after preoperative orthodontic treatment in patients with skeletal class III dentofacial deformities for analysis of muscle changes and malocclusions. Methods: Twenty female patients with dentofacial deformities were included in the study. Computed tomography was performed before and after preoperative orthodontic treatment, and the lengths, widths, and cross-sectional areas of the masseter muscles were measured. Changes in these parameters were evaluated, and factors related to changes in masseter muscle area after preoperative orthodontic treatment were analyzed. Results: The lengths, widths, and areas of masseter muscles were significantly smaller after preoperative orthodontic treatment. Smaller masseter muscle area was significantly associated with changes in overbite and pretreatment values of SNA angle. Conclusions: Atrophy of the masseter muscle during preoperative orthodontic treatment was greater in patients with increased open bite due to improved dental compensation in patients with skeletal class III dentofacial deformities with maxillary retraction.

1 August 2011 in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
Verified
Journal Article
Closed access
SYShinya Yura
Shinya Yura
OKOoi Kazuhiro
Ooi Kazuhiro
YIYuri Izumiyama
Yuri Izumiyama

1 January 2025 in Journal of Prosthodontic Research
Verified
Journal Article
Open access
PDF file
OKOoi Kazuhiro
Ooi Kazuhiro
ANAkira Nishiyama
Akira Nishiyama
HYHidemichi Yuasa
Hidemichi Yuasa
YYYoshihiro Yamaguchi
Yoshihiro Yamaguchi
TATakahiro Abe
Takahiro Abe
YMYoshizo Matsuka
Yoshizo Matsuka
Purpose: This guideline aimed to make evidence-based clinical practice guidelines for the primary treatment of temporomandibular disorders (TMDs) for general practitioners who do not specialize in TMD.Review process: Following the principles of evidence-based medicine, a systematic review and network meta-analysis (NMA) of multiple treatments was conducted, assessing the certainty of evidence using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Randomized controlled trials published between January 2000 and December 2020 were included. Patients diagnosed with TMD according to the Diagnostic Criteria for Temporomandibular Disorders were considered. Myalgia, arthralgia, and maximal mouth opening were selected as outcomes, and 12 treatments were included in the NMA. The modified Delphi method was used to reach a consensus on recommendations during clinical guideline panel meetings of the Japanese Society for the Temporomandibular Joint.Results: Self-administered mouth opening exercises, stabilization-type oral appliances, and low-level laser therapy (LLLT) were recognized as effective primary treatments, although the evidence level was graded as “very low” (Grade 2D). During the clinical guideline panel meetings, decisions were developed based on the NMA results, and recommendations for clinical practice guidelines were finalized following consensus.Conclusions: This guideline recommends mouth opening exercises and the use of stabilization-type oral appliances as primary treatments for TMD. Additionally, it suggests that LLLT be a conditional recommendation, supplemented with additional considerations.

11 March 2025 in Osteoarthritis and Cartilage Open
Verified
Journal Article
Open access
OKOoi Kazuhiro
Ooi Kazuhiro
KYKazuhiro Yamamoto
Kazuhiro Yamamoto
YKYutaka Kobayashi
Yutaka Kobayashi
BJBehzad Javaheri
Behzad Javaheri
AJAnders Jensen
Anders Jensen
GBGeorge Bou-Gharios
George Bou-Gharios
Temporomandibular joint osteoarthritis (TMJ-OA) is painful and causes masticatory dysfunction, but current treatment is limited to symptom relief due to an incomplete appreciation of aetiology. Herein, we develop morphological and histological methods for quantitative evaluation of TMJ-OA severity and examine whether STR/Ort mice, which are genetically predisposed to spontaneous knee OA, exhibit protection against TMJ-OA upon genetic gain-of-function modification of an aggrecanase-selective mutant of tissue inhibitor of metalloproteinase (TIMP)-3. We established morphological changes in mandibular condylar head adapted from human TMJ-OA criteria, and developed and verified the utility of TMJ-OA histological damage scoring adapted from the OARSI system. Mutant TIMP3 containing an extra alanine at the N-Terminus ([-1A] TIMP-3 was overexpressed in STR/Ort and CBA mice. Morphological changes in mandibular condyle and TMJ cartilage degradation were evaluated and quantified using micro-CT and histology in mice aged 10, 20 and 40 weeks. Whilst no evidence of TMJ-OA was observed in STR/Ort mice aged 10 weeks, bone erosion and osteophyte formation appeared in the mandibular condyle by 20 weeks, with remarkable deformity and bone resorption at 40 weeks in STR/Ort, but not the parental CBA strain. TMJ-OA was less severe in 40 week-old [-1A]TIMP-3 overexpressing STR/Ort and CBA compared to wild-type mice. Using our new mouse TMJ-OA scoring system we have found that OA affects joints other than the knee in the STR/Ort strain. Genetic gain-of-function modification of STR/Ort mice with an aggrecanase-selective mutant of tissue inhibitor of metalloproteinase (TIMP)-3 also affords in vivo chondroprotection against this TMJ-OA.